Abatacept Improves Post-Transplant Survival and Reduces Endothelial Injury Syndromes in Beta-Thalassemia major.
Sign Up to like & getrecommendations! Published in 2025 at "Blood advances"
DOI: 10.1182/bloodadvances.2025017197
Abstract: Key Points • Abatacept reduced incidence of endothelial injury syndromes and improved survival in patients with TDT.• Patients receiving abatacept did not experience grade 2 to 4 acute GVHD. read more here.
Keywords: abatacept improves; post transplant; endothelial injury; injury syndromes ... See more keywords